BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,975 | -29.2% | 1,033 | -14.5% | 0.02% | -34.3% |
| Q2 2023 | $55,036 | +1.8% | 1,208 | -9.4% | 0.04% | +2.9% |
| Q1 2023 | $54,066 | -37.9% | 1,333 | -22.0% | 0.03% | -35.8% |
| Q4 2022 | $87,054 | -5.4% | 1,708 | 0.0% | 0.05% | -14.5% |
| Q3 2022 | $92,000 | -14.0% | 1,708 | +2.0% | 0.06% | -11.4% |
| Q2 2022 | $107,000 | -17.7% | 1,675 | 0.0% | 0.07% | -11.4% |
| Q1 2022 | $130,000 | -9.7% | 1,675 | 0.0% | 0.08% | -10.2% |
| Q4 2021 | $144,000 | +7.5% | 1,675 | 0.0% | 0.09% | -1.1% |
| Q3 2021 | $134,000 | -0.7% | 1,675 | 0.0% | 0.09% | -1.1% |
| Q2 2021 | $135,000 | -4.3% | 1,675 | 0.0% | 0.09% | -8.2% |
| Q1 2021 | $141,000 | +5.2% | 1,675 | 0.0% | 0.10% | -1.0% |
| Q4 2020 | $134,000 | 0.0% | 1,675 | 0.0% | 0.10% | -13.2% |
| Q3 2020 | $134,000 | -6.9% | 1,675 | 0.0% | 0.11% | -7.3% |
| Q2 2020 | $144,000 | +5.9% | 1,675 | 0.0% | 0.12% | -1.6% |
| Q1 2020 | $136,000 | -2.9% | 1,675 | 0.0% | 0.12% | +22.5% |
| Q4 2019 | $140,000 | -4.1% | 1,675 | 0.0% | 0.10% | -10.5% |
| Q3 2019 | $146,000 | +6.6% | 1,675 | 0.0% | 0.11% | +2.7% |
| Q2 2019 | $137,000 | -9.9% | 1,675 | -10.7% | 0.11% | -2.6% |
| Q1 2019 | $152,000 | +22.6% | 1,875 | 0.0% | 0.11% | +14.0% |
| Q4 2018 | $124,000 | -3.9% | 1,875 | +11.9% | 0.10% | +19.0% |
| Q3 2018 | $129,000 | +4.0% | 1,675 | 0.0% | 0.08% | -3.4% |
| Q2 2018 | $124,000 | +13.8% | 1,675 | 0.0% | 0.09% | +11.5% |
| Q1 2018 | $109,000 | 0.0% | 1,675 | 0.0% | 0.08% | +11.4% |
| Q4 2017 | $109,000 | +3.8% | 1,675 | 0.0% | 0.07% | +1.4% |
| Q3 2017 | $105,000 | +2.9% | 1,675 | 0.0% | 0.07% | +6.2% |
| Q2 2017 | $102,000 | +17.2% | 1,675 | 0.0% | 0.06% | +18.2% |
| Q1 2017 | $87,000 | 0.0% | 1,675 | -15.2% | 0.06% | +5.8% |
| Q4 2016 | $87,000 | +20.8% | 1,975 | +31.7% | 0.05% | +20.9% |
| Q3 2016 | $72,000 | -38.5% | 1,500 | -41.9% | 0.04% | -36.8% |
| Q2 2016 | $117,000 | -53.8% | 2,583 | -58.2% | 0.07% | -48.5% |
| Q1 2016 | $253,000 | +3.7% | 6,173 | -3.4% | 0.13% | +2.3% |
| Q4 2015 | $244,000 | +6.1% | 6,388 | -9.0% | 0.13% | 0.0% |
| Q3 2015 | $230,000 | -56.8% | 7,019 | -7.9% | 0.13% | -52.2% |
| Q2 2015 | $532,000 | +16.2% | 7,619 | +14.0% | 0.27% | +16.9% |
| Q1 2015 | $458,000 | -4.6% | 6,682 | +2.0% | 0.23% | -3.3% |
| Q4 2014 | $480,000 | +11.9% | 6,551 | +9.5% | 0.24% | +12.2% |
| Q3 2014 | $429,000 | +14.4% | 5,981 | +15.4% | 0.21% | +18.3% |
| Q2 2014 | $375,000 | -1.8% | 5,181 | 0.0% | 0.18% | -2.2% |
| Q1 2014 | $382,000 | +8.2% | 5,181 | +2.0% | 0.18% | +11.5% |
| Q4 2013 | $353,000 | -35.0% | 5,081 | -38.5% | 0.16% | -38.2% |
| Q3 2013 | $543,000 | -8.0% | 8,266 | -2.9% | 0.27% | -8.9% |
| Q2 2013 | $590,000 | – | 8,516 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |